Digestive Diseases and Sciences

, Volume 55, Issue 10, pp 2929–2939 | Cite as

Upregulated Expression of hITF in Crohn’s Disease and Screening of hITF Interactant by a Yeast Two-Hybrid System

  • Huaxiu Shi
  • Jianlin Ren
  • Hongzhi Xu
  • Jinshui Pan
  • Xiaoyan Hao
  • Lydia Leyland Barlow
  • Weiguo DongEmail author
Original Article



To study the expression of human intestinal trefoil factor (hITF) mRNA in Crohn’s disease and to screen the cellular proteins that can interact with the hITF protein by a yeast two-hybrid system in order to explore the mechanism of hITF in protecting intestinal mucosa from injury.


Seventy-eight patients underwent double-balloon enteroscopy (DBE). Expression of hITF mRNA was detected by quantitative real-time polymerase chain reaction analysis (qRT-PCR). The hITF gene was amplified by PCR and cloned into vector pDEST32. The yeast cells cotransformed with pDEST32-hITF and the human jejunal cDNA library were plated in a selective SC-Leu-Trp-His-Ura medium. The subsequent screen was performed with χ-gal detection, and true-positive clones were sequenced and analyzed with bioinformatics. Co-immunoprecipitation (Co-IP) was performed to confirm the binding of putative proteins to the hITF protein.


Thirty-nine patients were diagnosed with Crohn’s disease. We found that the expression of hITF mRNA is significantly increased in Crohn’s disease compared to normal controls. A total of ten colonies were selected and sequenced. Among these, six colonies were Homo sapiens zinc finger protein 193 (ZNF193), three colonies were Homo sapiens Aldo–keto reductase family 1C 1 (AKR1C1), and one colony was of an unknown gene. A reverse two-hybrid experiment and Co-IP indicated that ZNF193 and AKR1C1 might interact with hITF.


The expression of hITF mRNA is increased in Crohn’s disease. ZNF193 and AKR1C1 are proteins that can interact with the hITF protein by a yeast two-hybrid system and Co-IP, hITF may contribute to the mucosal repair through this interaction.


Human intestinal trefoil factor Crohn’s disease Yeast two-hybrid system 



This work was supported in part by grant WQK05022005 from the Science and Technology Innovation Foundation of Fujian Province, China. The authors are grateful to the Department of Gastroenterology, Zhongshan Hospital, Xiamen University and the Department of Surgery, Renji Hospital of Shanghai Jiaotong Medical University. We thank Ms. Lydia Leyland Barlow and Dr. Wenyu Lin for their help in this manuscript edition.


  1. 1.
    Taupin D, Wu DC, Jeon WK, Devaney K, Wang TC, Podolsky DK. The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation. J Clin Invest. 1999;103:31–38.CrossRefGoogle Scholar
  2. 2.
    Teng X, Xu LF, Zhou P, Sun HW, Sun M. Effects of trefoil peptide 3 on expression of TNF-alpha, TLR4, and NF-kappaB in trinitrobenzene sulphonic acid induced colitis mice. Inflammation. 2009;32:120–129.CrossRefPubMedGoogle Scholar
  3. 3.
    Kalabis J, Rosenberg I, Podolsky DK. Vangl1 protein acts as a downstream effector of intestinal trefoil factor (ITF)/TFF3 signaling and regulates wound healing of intestinal epithelium. J Biol Chem. 2006;281:6341–6434.CrossRefGoogle Scholar
  4. 4.
    Kjellev S, Thim L, Pyke C, Poulsen SS. Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice. Dig Dis Sci. 2007;52:1050–1059.CrossRefPubMedGoogle Scholar
  5. 5.
    Mahmood A, Melley L, Fitzgerald AJ, Ghosh S, Playford RJ. Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis. Aliment Pharmacol Ther. 2005;21:1357–1364.CrossRefPubMedGoogle Scholar
  6. 6.
    Grønbaek H, Vestergaard EM, Hey H, Nielsen JN, Nexø E. Serum trefoil factors in patients with inflammatory bowel disease. Digestion. 2006;74:33–39.CrossRefPubMedGoogle Scholar
  7. 7.
    Poulsom R, Chinery R, Sarraf C, et al. Trefoil peptide gene expression in small intestinal Crohn’s disease and dietary adaptation. J Clin Gastroenterol. 1993;17:78–91.CrossRefGoogle Scholar
  8. 8.
    Yamamoto H, Sekine Y, Sato Y, et al. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc. 2001;53:216–220.CrossRefPubMedGoogle Scholar
  9. 9.
    Su MY, Liu NJ, Hsu CM, Chiu CT, Chen PC, Lin CJ. Double-balloon enteroscopy—the last blind-point of the gastrointestinal tract. Dig Dis Sci. 2005;50:1041–1045.CrossRefPubMedGoogle Scholar
  10. 10.
    Zhong J, Ma T, Zhang C, et al. A retrospective study of the application on double-balloon enteroscopy in 378 patients with suspected small-bowel diseases. Endoscopy. 2007;39:208–215.CrossRefPubMedGoogle Scholar
  11. 11.
    Beck PL, Wong JF, Li Y, et al. Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology. 2004;126:796–808.CrossRefPubMedGoogle Scholar
  12. 12.
    Loncar MB, Al-azzeh ED, Sommer PS, et al. Tumour necrosis factor alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide. Gut. 2003;52:1297–1303.CrossRefPubMedGoogle Scholar
  13. 13.
    Paulsen FP, Woon CW, Varoga D, et al. Intestinal trefoil factor/TFF3 promotes re-epithelialization of corneal wounds. J Biol Chem. 2008;283:13418–13427.CrossRefPubMedGoogle Scholar
  14. 14.
    Marchbank T, Cox HM, Goodlad RA, et al. Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice. J Biol Chem. 2001;276:24088–24096.CrossRefPubMedGoogle Scholar
  15. 15.
    Podolsky DK, Gerken G, Eyking A, Cario E. Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology. 2009;137:209–220.CrossRefPubMedGoogle Scholar
  16. 16.
    Ross A, Mehdizadeh S, Tokar J, et al. Double-balloon enteroscopy detects small bowel mass lesions missed by capsule endoscopy. Dig Dis Sci. 2008;53:2140–2143.CrossRefPubMedGoogle Scholar
  17. 17.
    May A, Nachbar L, Pohl J, Ell C. Endoscopic interventions in the small bowel using double-balloon enteroscopy: feasibility and limitations. Am J Gastroenterol. 2007;102:527–535.CrossRefPubMedGoogle Scholar
  18. 18.
    Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 1996;274:262–265.CrossRefPubMedGoogle Scholar
  19. 19.
    Feng ZM, Fang DC, Chen WS, Wang RQ. Rodent IRR-219 (IgGFcγBP) and rTFF3, expressed mainly in the intestinal mucosa, depleted during dextran sulfate sodium-induced colitis. Dig Dis Sci. 2007;52:2104–2112.CrossRefPubMedGoogle Scholar
  20. 20.
    Taupin DR, Kinoshita K, Podolsky DK. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci USA. 2000;97:799–804.CrossRefPubMedGoogle Scholar
  21. 21.
    Longman RJ, Douthwaite J, Sylvester PA, et al. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut. 2000;47:792–800.CrossRefPubMedGoogle Scholar
  22. 22.
    Tan XD, Hsueh W, Chang H, Wei KR, Gonzalez-Crussi F. Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting. Biochem Biophys Res Commun. 1997;237:673–677.CrossRefPubMedGoogle Scholar
  23. 23.
    Berggård T, Linse S, James P. Methods for the detection and analysis of protein–protein interactions. Proteomics. 2007;7:2833–2842.CrossRefPubMedGoogle Scholar
  24. 24.
    Von Mering C, Krause R, Snel B, et al. Comparative assessment of large-scale data sets of protein–protein interactions. Nature. 2002;417:399–403.CrossRefGoogle Scholar
  25. 25.
    Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y. A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA. 2001;98:4569–4574.CrossRefPubMedGoogle Scholar
  26. 26.
    Free RB, Hazelwood LA, Sibley DR. Identifying novel protein-protein interactions using Co-IP and mass spectroscopy. Curr Protoc Neurosci 2009; Chapter 5: Unit 5.28.Google Scholar
  27. 27.
    Dickson C. Protein techniques: immunoprecipitation, in vitro kinase assays, and Western blotting. Methods Mol Biol. 2008;461:735–744.CrossRefPubMedGoogle Scholar
  28. 28.
    Lee PL, Gelbart T, West C, Adams M, Blackstone R, Beutler E. Three genes encoding zinc finger proteins on human chromosome 6p21.3: members of a new subclass of the Kruppel gene family containing the conserved SCAN box domain. Genomics. 1997;43:191–201.CrossRefPubMedGoogle Scholar
  29. 29.
    Sasaki O, Meguro K, Tohmiya Y, Funato T, Shibahara S, Sasaki T. Nucleotide alteration of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukemia. Tohoku J Exp Med. 2002;196:193–201.CrossRefPubMedGoogle Scholar
  30. 30.
    Imanishi M, Nakamura A, Morisaki T, Futaki S. Positive and negative cooperativity of modularly assembled zinc fingers. Biochem Biophys Res Commun. 2009;387:440–443.CrossRefPubMedGoogle Scholar
  31. 31.
    Zhang Y, Dufort I, Rheault P, Luu-The V. Characterization of a human 20alpha-hydroxysteroid dehydrogenase. J Mol Endocrinol. 2000;25:221–228.CrossRefPubMedGoogle Scholar
  32. 32.
    Brozic P, Smuc T, Gobec S, Rizner TL. Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1. Mol Cell Endocrinol. 2006;259:30–42.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Huaxiu Shi
    • 1
    • 2
    • 3
  • Jianlin Ren
    • 2
  • Hongzhi Xu
    • 2
  • Jinshui Pan
    • 2
  • Xiaoyan Hao
    • 2
  • Lydia Leyland Barlow
    • 3
  • Weiguo Dong
    • 1
    Email author
  1. 1.Department of GastroenterologyRenmin Hospital of Wuhan UniversityWuhanChina
  2. 2.Department of GastroenterologyZhongshan Hospital Xiamen UniversityXiamenChina
  3. 3.Gastrointestinal Unit, Center for the Study of Inflammatory Bowel DiseaseMassachusetts General Hospital and Harvard Medical SchoolBostonUSA

Personalised recommendations